Inventor · disambiguated record
Gen Unoki
Also filed as: UNOKI GEN
10 granted patents·3 pending applications·88 citations·filing 2003–2017
86Inventor score
Top patents by PatentIndex Score
13 records- 0185US7557110B2Pyrazolo[1,5-A] pyrimidine derivativesTEIJIN PHARMA LTD·Filed 2004·Granted Jul 7, 2009·44 cites·53 claims
- 0284US7557113B2Substituted pyrrolo[3,2-d]pyrimidine derivativesTEIJIN PHARMA LTD·Filed 2004·Granted Jul 7, 2009·26 cites·39 claims
- 0382US7417053B2Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereofTEIJIN PHARMA LTD·Filed 2006·Granted Aug 26, 2008·6 cites·53 claims
- 0478US7473694B2Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereofTEIJIN PHARMA LTD·Filed 2006·Granted Jan 6, 2009·4 cites·42 claims
- 0575US7667036B2Pyrazolo[1,5-a]pyrimidine derivativesTEIJIN PHARMA LTD·Filed 2005·Granted Feb 23, 2010·3 cites·31 claims
- 0669US11084814B2Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereofTEIJIN PHARMA LTD·Filed 2017·Granted Aug 10, 2021·1 cites·27 claims
- 0765US7528140B2Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitorsTEIJIN LTD·Filed 2003·Granted May 5, 2009·3 cites·92 claims
- 0863US10124004B2Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereofTEIJIN PHARMA LTD·Filed 2016·Granted Nov 13, 2018·1 cites·27 claims
- 0956US2009054472A1Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts ThereofTEIJIN PHARMA LTD·Filed 2008·Application pending·0 cites
- 1049US2009291945A1Cysteine protease inhibitorsTEIJIN PHARMA LTD·Filed 2009·Application pending·0 cites
- 1148US11261182B2Crystal of pyrido[3,4-d]pyrimidine derivative or solvate thereofTEIJIN PHARMA LTD·Filed 2017·Granted Mar 1, 2022·0 cites·41 claims
- 1245US2005153992A1Pyrrolopyrimidine thion derivativesTEIJIN PHARMA LTD·Filed 2004·Application pending·0 cites
- 1331US10689354B2Aminoazole derivativeTEIJIN PHARMA LTD·Filed 2016·Granted Jun 23, 2020·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →